Kerckhoff-Klinik GmbH
Kerckhoff-Klinik GmbH
Bad Nauheim, Germany3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SGLT2 Inhibitor Treatment Admitted for Acute Decompensated Heart Failure | Acute Decompensated Heart Failure (ADHF) | Recruiting | Phase 3 | 2026-08-26 | NCT07038356 | |
| From the Emergency Department Directly to Ablation of Atrial Fibrillation Study | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Active, not recruiting | Not applicable | 2026-05-22 | NCT05294445 | |
| Impact of Beta-blocker on Outcome Among Patients Undergoing Transcatheter Aortic Valve Replacement (B-TAVR) | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Recruiting | Not applicable | 2025-11-28 | NCT06472934 |